New Times,
New Thinking.

  1. Business
  2. Economics
14 November 2012

The Bank of England warns Osborne: prepare for a triple-dip recession

Osborne said the economy was "on the right track" but the Bank warns growth could disappear in Q4.

By George Eaton

It was always unwise for George Osborne to cite the most recent set of growth figures as proof that “we’re on the right track“, principally because the good news is unlikely to last. Growth in quarter three, which stood at one per cent, was artificially inflated by the Olympics (which added 0.2 per cent to growth) and by the bounce back from the Jubilee bank holiday (which added 0.5 per cent). There was, as I wrote when the figures were published, a strong chance of a contraction in the fourth quarter.

Now the Bank of England has become the latest forecaster to warn of the possibility of a triple-dip recession. In its quarterly inflation report, it notes that

Headline outturns for GDP in 2012 have been, and will continue to be, volatile, with the data buffeted by one-off influences such as the Jubilee and the Olympics. In Q3, output increased by 1%. In Q4, that growth rate seems set to fall sharply as the boost from the Olympics is reversed; indeed, output may post a small decline [emphasis mine].

Having claimed that the economy is “healing”, Osborne will struggle to explain why the patient has taken another turn for the worse.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines